Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.
Mandate

Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.

May 22, 2020 Banking and Finance M&A EU, Competition and Regulatory

Vinge has advised Fidelio Capital on the acquisition of Veterinary Orthopedic Implants, Inc (“VOI”).

VOI is a fast-growing US company within the market for veterinary orthopedic implants and instruments.

Vinge’s team consisted of, among others, Jonas Bergström, Manne Bergström, Johanna Wiberg and Carl-Fredrik Wachtmeister (M&A/Corporate), Albert Wållgren and Axel Jansson (Banking and Finance), Johan Karlsson, Sebastian Örndahl and Lisa Malmborg (Competition) and Christoffer Widström (VDR-specialist).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025